Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

45

Number of overlapping holdings

73.8%

% of BBP's 65 holdings also in XBI

33.1%

% of XBI's 136 holdings also in BBP

Overlap by Weight
Sector Drift (BBP minus XBI)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBP
Weight
in XBI
Overlap
ALNYLAM PHARMACEUTICALS INC 2.1% 2.5% 2.1%
INSMED INC 1.8% 2.6% 1.8%
GILEAD SCIENCES INC 1.8% 3.0% 1.8%
TG THERAPEUTICS INC 1.8% 1.7% 1.7%
UNITED THERAPEUTICS CORP 1.7% 2.9% 1.7%

Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to XBI
LIGAND PHARMACEUTICALS-CL B 1.9%
LEXICON PHARMACEUTICALS, INC. 1.9%
LEGEND BIOTECH CORPORATION SPONSORED 1.9%
MIRUM PHARMACEUTICALS, INC. 1.8%
THERAVANCE BIOPHARMA INC 1.8%
TRAVERE THERAPEUTICS, INC. 1.7%
AXSOME THERAPEUTICS, INC. 1.7%
INTRA-CELLULAR THERAPIES INC 1.7%
HARMONY BIOSCIENCES HOLDINGS, INC. 1.7%
PHATHOM PHARMACEUTICALS, INC. 1.6%
BBP Underweight Relative to XBI
NATERA INC -3.5%
ADVENTRX PHARMACEUTICALS INC -2.8%
EXACT SCIENCES CORP -2.5%
ABBVIE INC -2.4%
VIKING THERAPEUTICS, INC. -1.9%
CYTOKINETICS INC -1.6%
INCYTE CORP -1.3%
ALKERMES PLC -1.2%
NEUROCRINE BIOSCIENCES INC -1.2%
REVOLUTION MEDICINES, INC. -1.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY